|
|
||||||||


* Weizmann Institute of Science, Rehovot, Israel; and
Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Israel
T cells may encounter glutamate, the major excitatory neurotransmitter in the nervous system, when patrolling the brain and in glutamate-rich peripheral organs. Moreover, glutamate levels increase in the CNS in many pathological conditions in which T cells exert either beneficial or detrimental effects. We discovered that normal human T cells, human T leukemia cells, and mouse anti-myelin basic protein T cells express high levels of glutamate ion channel receptor (ionotropic) of
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) subtype 3 (GluR3). The evidence for GluR3 on T cells includes GluR3-specific RT-PCR, Western blot, immunocytochemical staining and flow cytometry. Sequencing showed that the T cell-expressed GluR3 is identical with the brain GluR3. Glutamate (10 nM), in the absence of any additional molecule, triggered T cell function: integrin-mediated T cell adhesion to laminin and fibronectin, a function normally performed by activated T cells only. The effect of glutamate was mimicked by AMPA receptor-agonists and blocked specifically by the selective receptor-antagonists 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 6-nitro-7-sulfamoylbenzo[f]quinoxalin-2,3-dione (NBQX), and by relevant anti-integrin mAbs. Glutamate also increased the CXCR4-mediated T cell chemotactic migration toward the key chemokine CXCL12/stromal cell-derived factor-1. GluR3 expression on normal, cancer and autoimmune-associated T cells and the ability of glutamate to directly activate T cell function could be of substantial scientific and clinical importance to normal neuroimmune dialogues and to CNS diseases and injury, and especially to: 1) T cell transmigration to the CNS and patrolling in the brain, 2) T cell-mediated multiple sclerosis, and 3) autoimmune epilepsy, as neurotoxic anti-GluR3 Abs are found and suspected to cause/potentiate seizures and neuropathology in several types of human epilepsies. Thus far, GluR3 was found only on neurons and glia cells; our results reveal a novel peripheral source of this antigenic receptor.
This article has been cited by other articles:
![]() |
I. P. Greene, E.-Y. Lee, N. Prow, B. Ngwang, and D. E. Griffin Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection PNAS, March 4, 2008; 105(9): 3575 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Levite Response to Comment on "TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage" J. Immunol., February 15, 2008; 180(4): 2007 - 2007. [Full Text] [PDF] |
||||
![]() |
Y. Ganor, V. I. Teichberg, and M. Levite TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage J. Immunol., January 15, 2007; 178(2): 683 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pacheco, H. Oliva, J. M. Martinez-Navio, N. Climent, F. Ciruela, J. M. Gatell, T. Gallart, J. Mallol, C. Lluis, and R. Franco Glutamate Released by Dendritic Cells as a Novel Modulator of T Cell Activation J. Immunol., November 15, 2006; 177(10): 6695 - 6704. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Poulopoulou, I. Markakis, P. Davaki, C. Nikolaou, A. Poulopoulos, E. Raptis, and D. Vassilopoulos Modulation of Voltage-Gated Potassium Channels in Human T Lymphocytes by Extracellular Glutamate Mol. Pharmacol., March 1, 2005; 67(3): 856 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pacheco, F. Ciruela, V. Casado, J. Mallol, T. Gallart, C. Lluis, and R. Franco Group I Metabotropic Glutamate Receptors Mediate a Dual Role of Glutamate in T Cell Activation J. Biol. Chem., August 6, 2004; 279(32): 33352 - 33358. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Sinclair, A. Sorour, M. Martineau, C. J. Harrison, W. A. Mitchell, E. O'Neill, and L. Foroni A Fluorescence in Situ Hybridization Map of 6q Deletions in Acute Lymphocytic Leukemia: Identification and Analysis of a Candidate Tumor Suppressor Gene Cancer Res., June 15, 2004; 64(12): 4089 - 4098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Kanwar, R. K. Kanwar, and G. W. Krissansen Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis Brain, June 1, 2004; 127(6): 1313 - 1331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |